CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
positron emission tomography/computed tomography +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01892540
NCT01892540N/ACompleted
CompareCT.gov

Positron Mammographic Imaging (PMI)

Case Comprehensive Cancer Center·interventional·Posted Jul 4, 2013·Updated Mar 4, 2020

In Brief

A clinical study evaluating positron emission tomography/computed tomography, PET/MRI, and 1 other intervention for Breast Cancer and Unspecified Adult Solid Tumor, Protocol Specific. Completed, enrolled 43 participants across 1 site.

Detailed Summary

This clinical trial studies positron emission tomography (PET)/computed tomography (CT) or PET/magnetic resonance imaging (MRI) in measuring tumors in patients undergoing clinical imaging or with newly diagnosed breast cancer. New diagnostic procedures, such as PET/CT or PET/MRI, may be more effective than MRI alone in measuring tumors in patients undergoing clinical imaging or with newly diagnosed breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Unspecified Adult Solid Tumor, Protocol Specific
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 4, 2013
Enrollment StartMay 1, 2013
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 13.0 years ago

Interventions

positron emission tomography/computed tomographyother

Undergo PET/CT

PET/MRIother

Undergo PET/MRI positron emission tomography/magnetic resonance imaging hybrid imaging

Position Devicedevice